💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Incyte Corporation (INCY)
« Back to company indexINCY Chatter Timeline
Stock Ticker for INCY
Most Active Tweeters for INCY
| User | Tweets |
|---|---|
| @TShortalgo | 10 |
| @YDMU_Markets | 10 |
| @Beeken_health | 9 |
| @Slayer10Stock | 9 |
| @TradingSin21 | 7 |
Recent Tweets for INCY
 |
@PaigePe50382962 $incy Top analyst price target for next week??https://t.co/E6DIYRZZZW March 21st 2023, 5:03pm |
 |
@TradingSin21 $INCY Trading Ideas | Awaiting Short signal. 100% Profitability based on 9 trades. Profit factor is 100. Learn more… https://t.co/JSU9gT9gvb March 21st 2023, 1:03pm |
 |
@TShortalgo $INCY Trading Ideas | Awaiting Short signal. 90.91% Profitability based on 12 trades. Profit factor is 26.65. Learn… https://t.co/eilWEcndz7 March 21st 2023, 4:03am |
 |
@Genevie09104466 $incy Top analyst price target for next week-- https://t.co/r9TY7zvDB4 March 21st 2023, 3:03am |
 |
@MaryMit78504868 $INCY ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED - https://t.co/4pQ6g54Aml March 21st 2023, 2:03am |
 |
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 798 March 20th 2023, 10:03pm |
|
@mediasentiment $INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 797 March 20th 2023, 10:03pm |
|
@TradingSin21 $INCY Trading Ideas | Awaiting Short signal. 100% Profitability based on 8 trades. Profit factor is 100. Learn more… https://t.co/fRX5VKmV1i March 20th 2023, 5:03pm |
 |
@Penelop61419357 $incy Top analyst price target for next week??https://t.co/9MEZ1bXNZJ March 20th 2023, 5:03pm |
 |
@LeviTrade2 $INCY Trading Signals | Awaiting Short signal. 100% Win Rate based on 11 trades. Profit factor is 100. #stocks… https://t.co/Ye9uCir7tE March 20th 2023, 4:03pm |
 |
@Isabell63298945 $incy Top analyst price target for next week-- https://t.co/8Mc1hywA0A March 20th 2023, 2:03pm |
 |
@MarketCurrents $INCY - Incyte says mid-stage trial for vitiligo therapy met main goal https://t.co/jHArv3qaXS March 20th 2023, 12:03pm |
 |
@bthefirsttoknow First out// $INCY: SVB Leerink Maintains Underperform on Incyte, Lowers Price Target to $60 https://t.co/Fv04tQYdWx March 20th 2023, 11:03am |
 |
@Slayer10Stock $INCY Awaiting Buy Signal based off 7 signals $890 net profit 6.21 profit factor 85% win rate on a 15-min chart. Fr… https://t.co/5nzoFvAQD9 March 20th 2023, 9:03am |
 |
@StckPro $INCY NEW ARTICLE : Incyte (INCY) Receives a Hold from Mizuho Securities https://t.co/MV3tLXzA1l March 20th 2023, 12:03am |
|
@TradingSin21 $INCY Trading Ideas | Awaiting Short signal. 100% Profitability based on 8 trades. Profit factor is 100. Learn more… https://t.co/aTggA4T9tF March 19th 2023, 8:03pm |
 |
@algobotnews Incyte announces data from Phase 2b study evaluating Povorcitinib $INCY March 19th 2023, 7:03pm |
 |
@WallStSai @Andre_AGTC @astraystargazer Looks like $INCY just release ph3 data March 19th 2023, 7:03pm |
|
@algobotnews Incyte announces long-term extension data from Phase 3 TRuE-V program $INCY March 19th 2023, 7:03pm |
 |
@BoitechB @AaronRosenblum5 @XBIObserver $INCY is far from done. BB has long investment timelines, so I could see them adding… https://t.co/nxTqeHIHBx March 19th 2023, 5:03pm |
 |
@AaronRosenblum5 @BoitechB @XBIObserver How does putting more money into $incy at current valuation make any sense. A big pharma isn… https://t.co/WvLKKRDyb3 March 19th 2023, 5:03pm |
 |
@EllaOrt57506845 $incy Top analyst price target for next week??https://t.co/3UzJ2qChYF March 19th 2023, 5:03pm |
|
@BoitechB @XBIObserver Wouldn't be surprised to see BB take the cash from $PFE and see them sprinkle some more into $INCY and… https://t.co/DyxOILU44Z March 19th 2023, 5:03pm |
 |
@TortozaPalma $INCY Awaiting Short Signal based off 9 signals on the 15-min chart. Free trial at https://t.co/OB4KuLJjyA https://t.co/ixN3dXQx73 March 19th 2023, 2:03pm |
 |
@MaryCar59919582 $INCY ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED - https://t.co/Q5Qllf8Qz7 March 19th 2023, 3:03am |
|
@TShortalgo $INCY Trading Ideas | Awaiting Buy signal. 88.24% Profitability based on 20 trades. Profit factor is 5.23. Learn mo… https://t.co/HUdqSHcynx March 19th 2023, 2:03am |
 |
@DanielJanicemc $incy Real time Stock analyses ratings and target your prices https://t.co/Mwhx3yYq0a ?? March 19th 2023, 2:03am |
 |
@Kevin_M_Biotech $incy this #AAD2023 vitiligo webcast seems a bit like an overkill.. asians have problems getting married if you hav… https://t.co/LCyICqHcX7 March 18th 2023, 11:03pm |
 |
@Beeken_health $INCY - Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive No… https://t.co/hLsuntj12C March 18th 2023, 9:03pm |
 |
@otcdynamics $INCY Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nons… https://t.co/tOPKCN68ej March 18th 2023, 9:03pm |
|
@Beeken_health $INCY - Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive No… https://t.co/lFVgKROYhR March 18th 2023, 9:03pm |
|
@TortozaPalma $INCY Awaiting Short Signal based off 9 signals on the 15-min chart. Free trial at https://t.co/OB4KuLJjyA https://t.co/tf6QvWyfos March 18th 2023, 8:03pm |
|
@Beeken_health $INCY - Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive No… https://t.co/UkVISRxD42 March 18th 2023, 8:03pm |
 |
@IncredibleTrade $INCY Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nons… https://t.co/uuctgKkLK2 March 18th 2023, 8:03pm |
|
@Beeken_health $INCY - Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive No… https://t.co/IcmVHszhfW March 18th 2023, 8:03pm |
|
@StckPro $INCY NEW ARTICLE : Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with… https://t.co/BFFsnZFG40 March 18th 2023, 7:03pm |
 |
@StockNewsBot2 $INCY Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nons… https://t.co/dVXZ6JXoOV March 18th 2023, 7:03pm |
 |
@stock_titan $INCY Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nons… https://t.co/aGgs2LJTtC March 18th 2023, 7:03pm |
 |
@WebChronicleTo1 $INCY Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nons… https://t.co/rbGe1ODFXT March 18th 2023, 7:03pm |
|
@bthefirsttoknow First out// $INCY: Incyte Announces Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental March 18th 2023, 7:03pm |
 |
@ShortAlgoTrades $INCY Trading Ideas | Awaiting Short signal. 100% Profitability based on 11 trades. Win rate is 100. #trading… https://t.co/dzT2WLMAhR March 18th 2023, 6:03pm |
 |
@Adeline60327104 $incy Top analyst price target for next week??https://t.co/SXcCRpRU4f March 18th 2023, 5:03pm |
|
@StckPro $INCY NEW ARTICLE : Incyte Announces Long-Term Extension Data from Phase 3 TRuE-V Program Demonstrating Long-Term S… https://t.co/CJ4jOZdFS9 March 18th 2023, 3:03pm |
 |
@RossCra41038894 $INCY Top analyst price target for next week -->?? https://t.co/fDK5UdXRBx March 18th 2023, 2:03pm |
 |
@UsMarketNews $INCY news Incyte Announces Long-Term Extension Data from Phase 3 TRuE-V Program Demonstrating Long-Term Safety and… https://t.co/cBjxOfGRz8 March 18th 2023, 2:03pm |
 |
@Keith82084334 $incy Top analyst price target for next week-. https://t.co/tIBKEI3IJN March 18th 2023, 2:03pm |
|
@TradingSin21 $INCY Trading Ideas | Awaiting Short signal. 100% Profitability based on 8 trades. Profit factor is 100. Learn more… https://t.co/187JrveI1g March 18th 2023, 11:03am |
|
@TShortalgo $INCY Trading Ideas | Awaiting Buy signal. 88.24% Profitability based on 20 trades. Profit factor is 5.23. Learn mo… https://t.co/VAMQ8KNWn9 March 18th 2023, 2:03am |
 |
@optioncharts $INCY Implied Volatility expiration 03/17/2023 #maxpain #options https://t.co/bzQO6ZlLKu https://t.co/2ux2Wk3ey5 March 18th 2023, 2:03am |
 |
@Veronic67048523 $incy Top analyst price target for next week??https://t.co/rIBJQ4Ew1n March 17th 2023, 10:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.